Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT ID: NCT01572792

Last Updated: 2017-04-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

921 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this Phase III study is to evaluate the long-term safety and tolerability of two fixed-dose combinations of inhaled aclidinium bromide/formoterol fumarate, aclidinium bromide, formoterol fumarate and placebo in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD). Long-term efficacy, pharmacoeconomic and health-related quality of life assessments will also be evaluated. This extension study will include a 28 week treatment period, followed by a four week follow up visit. All patients will remain in the same treatment group as for the lead-in study and continue on one of the four treatment arms or placebo.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) high dose

Group Type EXPERIMENTAL

Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)

Intervention Type DRUG

Inhaled Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) high dose, twice per day

2

Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) low dose

Group Type EXPERIMENTAL

Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)

Intervention Type DRUG

Inhaled Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) low dose, twice per day

3

Aclidinium bromide 400 μg

Group Type ACTIVE_COMPARATOR

Aclidinium bromide

Intervention Type DRUG

Inhaled Aclidinium bromide 400 μg, twice per day

4

Formoterol Fumarate 12 μg

Group Type ACTIVE_COMPARATOR

Formoterol Fumarate

Intervention Type DRUG

Inhaled Formoterol Fumarate 12 μg, twice per day

5

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Inhaled dose-matched placebo, twice per day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)

Inhaled Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) high dose, twice per day

Intervention Type DRUG

Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)

Inhaled Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) low dose, twice per day

Intervention Type DRUG

Aclidinium bromide

Inhaled Aclidinium bromide 400 μg, twice per day

Intervention Type DRUG

Formoterol Fumarate

Inhaled Formoterol Fumarate 12 μg, twice per day

Intervention Type DRUG

Placebo

Inhaled dose-matched placebo, twice per day

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Completion of the treatment phase of the lead-in study, LAC-MD-31
* Written informed consent obtained from the patient before the initiation of any study specific procedures
* No medical contraindication as judged by the PI
* Compliance with LAC-MD-31 study procedures and IP dosing.
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Esther Garcia, MD

Role: STUDY_DIRECTOR

AstraZeneca

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Forest Investigative Site 1827

Anniston, Alabama, United States

Site Status

Forest Investigative Site 1920

Athens, Alabama, United States

Site Status

Forest Investigative Site 1162

Birmingham, Alabama, United States

Site Status

Forest Investigative Site 1493

Birmingham, Alabama, United States

Site Status

Forest Investigative Site 1937

Birmingham, Alabama, United States

Site Status

Forest Investigative Site 1824

Gulf Shores, Alabama, United States

Site Status

Forest Investigative Site 2088

Jasper, Alabama, United States

Site Status

Forest Investigative Site 1918

Scottsboro, Alabama, United States

Site Status

Forest Investigative Site 0909

Glendale, Arizona, United States

Site Status

Forest Investigative Site 1379

Phoenix, Arizona, United States

Site Status

Forest Investigative Site 1822

Anaheim, California, United States

Site Status

Forest Investigative Site 1483

Buena Park, California, United States

Site Status

Forest Investigative Site 1156

Fresno, California, United States

Site Status

Forest Investigative Site 1871

Lincoln, California, United States

Site Status

Forest Investigative Site 1873

Los Angeles, California, United States

Site Status

Forest Investigative Site 2064

Riverside, California, United States

Site Status

Forest Investigative Site 1427

Sacramento, California, United States

Site Status

Forest Investigative Site 1866

Sacramento, California, United States

Site Status

Forest Investigative Site 1125

San Diego, California, United States

Site Status

Forest Investigative Site 2009

San Diego, California, United States

Site Status

Forest Investigative Site 1374

Torrance, California, United States

Site Status

Forest Investigative Site 1813

Tustin, California, United States

Site Status

Forest Investigative Site 1883

Vista, California, United States

Site Status

Forest Investigative Site 1380

Golden, Colorado, United States

Site Status

Forest Investigative Site 1137

Pueblo, Colorado, United States

Site Status

Forest Investigative Site 1327

Wheat Ridge, Colorado, United States

Site Status

Forest Investigative Site 1976

Waterbury, Connecticut, United States

Site Status

Forest Investigative Site 1821

Bay Pines, Florida, United States

Site Status

Forest Investigative Site 1154

Brandon, Florida, United States

Site Status

Forest Investigative Site 1944

Brandon, Florida, United States

Site Status

Forest Investigative Site 1364

Clearwater, Florida, United States

Site Status

Forest Investigative Site 1152

Clearwater, Florida, United States

Site Status

Forest Investigative Site 1875

Clearwater, Florida, United States

Site Status

Forest Investigative Site 1811

Covington, Florida, United States

Site Status

Forest Investigative Site 0670

DeLand, Florida, United States

Site Status

Forest Investigative Site 1516

Edgewater, Florida, United States

Site Status

Forest Investigative Site 0990

Fort Lauderdale, Florida, United States

Site Status

Forest Investigative Site 1513

Hialeah, Florida, United States

Site Status

Forest Investigative Site 1854

Hialeah, Florida, United States

Site Status

Forest Investigative Site 1882

Hollywood, Florida, United States

Site Status

Forest Investigative Site 1543

Jacksonville, Florida, United States

Site Status

Forest Investigative Site 1416

Kissimmee, Florida, United States

Site Status

Forest Investigative Site 1167

Melbourne, Florida, United States

Site Status

Forest Investigative Site 1432

Miami, Florida, United States

Site Status

Forest Investigative Site 1819

Naples, Florida, United States

Site Status

Forest Investigative Site 1808

North Miami, Florida, United States

Site Status

Forest Investigative Site 1950

Oldsmar, Florida, United States

Site Status

Forest Investigative Site 1145

Ormond Beach, Florida, United States

Site Status

Forest Investigative Site 1094

Panama City, Florida, United States

Site Status

Forest Investigative Site 1803

Pembroke Pines, Florida, United States

Site Status

Forest Investigative Site 0974

Pensacola, Florida, United States

Site Status

Forest Investigative Site 1817

Sarasota, Florida, United States

Site Status

Forest Investigative Site 1874

St. Petersburg, Florida, United States

Site Status

Forest Investigative Site 2082

Tamarac, Florida, United States

Site Status

Forest Investigative Site 2053

Tampa, Florida, United States

Site Status

Forest Investigative Site 2047

Tampa, Florida, United States

Site Status

Forest Investigative Site 1185

Winter Park, Florida, United States

Site Status

Forest Investigative Site 1860

Winter Park, Florida, United States

Site Status

Forest Investigative Site 1900

Atlanta, Georgia, United States

Site Status

Forest Investigative Site 0987

Austell, Georgia, United States

Site Status

Forest Investigative Site 1828

Canton, Georgia, United States

Site Status

Forest Investigative Site 1830

Marietta, Georgia, United States

Site Status

Forest Investigative Site 2089

Woodstock, Georgia, United States

Site Status

Forest Investigative Site 0679

Coeur d'Alene, Idaho, United States

Site Status

Forest Investigative Site 1858

Eagle, Idaho, United States

Site Status

Forest Investigative Site 1095

Normal, Illinois, United States

Site Status

Forest Investigative Site 1912

Normal, Illinois, United States

Site Status

Forest Investigative Site 2051

River Forest, Illinois, United States

Site Status

Forest Investigative Site 2033

Bowling Green, Kentucky, United States

Site Status

Forest Investigative Site 2085

Fort Mitchell, Kentucky, United States

Site Status

Forest Investigative Site 0539

Lexington, Kentucky, United States

Site Status

Forest Investigative Site 1478

Louisville, Kentucky, United States

Site Status

Forest Investigative Site 1519

Owensboro, Kentucky, United States

Site Status

Forest Investigative Site 1430

New Orleans, Louisiana, United States

Site Status

Forest Investigative Site 1812

Opelousas, Louisiana, United States

Site Status

Forest Investigative Site 1814

Bangor, Maine, United States

Site Status

Forest Investigative Site 1924

Baltimore, Maryland, United States

Site Status

Forest Investigative Site 1872

Wheaton, Maryland, United States

Site Status

Forest Investigative Site 1570

Fall River, Massachusetts, United States

Site Status

Forest Investigative Site 1852

Fall River, Massachusetts, United States

Site Status

Forest Investigative Site 1431

No. Dartmouth, Massachusetts, United States

Site Status

Forest Investigative Site 1892

Ann Arbor, Michigan, United States

Site Status

Forest Investigative Site 1342

Stevensville, Michigan, United States

Site Status

Forest Investigative Site 1487

Troy, Michigan, United States

Site Status

Forest Investigative Site 1128

Edina, Minnesota, United States

Site Status

Forest Investigative Site 1527

Fridley, Minnesota, United States

Site Status

Forest Investigative Site 2041

Minneapolis, Minnesota, United States

Site Status

Forest Investigative Site 1124

Minneapolis, Minnesota, United States

Site Status

Forest Investigative Site 1619

Plymouth, Minnesota, United States

Site Status

Forest Investigative Site 1118

Rochester, Minnesota, United States

Site Status

Forest Investigative Site 1884

Olive Branch, Mississippi, United States

Site Status

Forest Investigative Site 1602

Kansas City, Missouri, United States

Site Status

Forest Investigative Site 1587

N. Chesterfield, Missouri, United States

Site Status

Forest Investigative Site 2079

Saint Charles, Missouri, United States

Site Status

Forest Investigative Site 1856

Springfield, Missouri, United States

Site Status

Forest Investigative Site 1867

Springfield, Missouri, United States

Site Status

Forest Investigative Site 1399

St Louis, Missouri, United States

Site Status

Forest Investigative Site 1599

St Louis, Missouri, United States

Site Status

Forest Investigative Site 1831

Bozeman, Montana, United States

Site Status

Forest Investigative Site 1400

Missoula, Montana, United States

Site Status

Forest Investigative Site 1609

Bellevue, Nebraska, United States

Site Status

Forest Investigative Site 1948

Fremont, Nebraska, United States

Site Status

Forest Investigative Site 1815

Lincoln, Nebraska, United States

Site Status

Forest Investigative Site 1363

Omaha, Nebraska, United States

Site Status

Forest Investigative Site 1907

Omaha, Nebraska, United States

Site Status

Forest Investigative Site 1911

Omaha, Nebraska, United States

Site Status

Forest Investigative Site 1908

Omaha, Nebraska, United States

Site Status

Forest Investigative Site 1804

Omaha, Nebraska, United States

Site Status

Forest Investigative Site 1807

Henderson, Nevada, United States

Site Status

Forest Investigative Site 1834

Las Vegas, Nevada, United States

Site Status

Forest Investigative Site 1562

Las Vegas, Nevada, United States

Site Status

Forest Investigative Site 1559

Cherry Hill, New Jersey, United States

Site Status

Forest Investigative Site 1923

Hackensack, New Jersey, United States

Site Status

Forest Investigative Site 1949

Albuquerque, New Mexico, United States

Site Status

Forest Investigative Site 1151

Great Neck, New York, United States

Site Status

Forest Investigative Site 1489

Larchmont, New York, United States

Site Status

Forest Investigative Site 550

New York, New York, United States

Site Status

Forest Investigative Site 1425

New York, New York, United States

Site Status

Forest Investigative Site 2098

Rochester, New York, United States

Site Status

Forest Investigative Site 1392

Charlotte, North Carolina, United States

Site Status

Forest Investigative Site 2035

Elizabeth City, North Carolina, United States

Site Status

Forest Investigative Site 1366

High Point, North Carolina, United States

Site Status

Forest Investigative Site 1153

Raleigh, North Carolina, United States

Site Status

Forest Investigative Site 1823

Salisbury, North Carolina, United States

Site Status

Forest Investigative Site 1891

Cadiz, Ohio, United States

Site Status

Forest Investigative Site 1134

Canton, Ohio, United States

Site Status

Forest Investigative Site 1885

Cincinnati, Ohio, United States

Site Status

Forest Investigative Site 1806

Cincinnati, Ohio, United States

Site Status

Forest Investigative Site 2028

Cincinnati, Ohio, United States

Site Status

Forest Investigative Site 1903

Cincinnati, Ohio, United States

Site Status

Forest Investigative Site 1361

Columbus, Ohio, United States

Site Status

Forest Investigative Site 1433

Columbus, Ohio, United States

Site Status

Forest Investigative Site 2090

Sylvania, Ohio, United States

Site Status

Forest Investigative Site 1530

Toledo, Ohio, United States

Site Status

Forest Investigative Site 1393

Zanesville, Ohio, United States

Site Status

Forest Investigative Site 1915

Oklahoma City, Oklahoma, United States

Site Status

Forest Investigative Site 1889

Bend, Oregon, United States

Site Status

Forest Investigative Site 2043

Medford, Oregon, United States

Site Status

Forest Investigative Site 1833

Altoona, Pennsylvania, United States

Site Status

Forest Investigative Site 1820

Downington, Pennsylvania, United States

Site Status

Forest Investigative Site 1423

Erie, Pennsylvania, United States

Site Status

Forest Investigative Site 1899

Langhorne, Pennsylvania, United States

Site Status

Forest Investigative Site 1443

Philadelphia, Pennsylvania, United States

Site Status

Forest Investigative Site 1863

Phoenixville, Pennsylvania, United States

Site Status

Forest Investigative Site 1146

Pittsburgh, Pennsylvania, United States

Site Status

Forest Investigative Site 1449

Tipton, Pennsylvania, United States

Site Status

Forest Investigative Site 1862

Uniontown, Pennsylvania, United States

Site Status

Forest Investigative Site 1832

Cumberland, Rhode Island, United States

Site Status

Forest Investigative Site 1089

East Providence, Rhode Island, United States

Site Status

Forest Investigative Site 2072

Charleston, South Carolina, United States

Site Status

Forest Investigative Site 1905

Charleston, South Carolina, United States

Site Status

Forest Investigative Site 1802

Charleston, South Carolina, United States

Site Status

Forest Investigative Site 1914

Fort Mill, South Carolina, United States

Site Status

Forest Investigative Site 1913

Gaffney, South Carolina, United States

Site Status

Forest Investigative Site 1121

Spartanburg, South Carolina, United States

Site Status

Forest Investigative Site 1957

Brentwood, Tennessee, United States

Site Status

Forest Investigative Site 1526

Fayetteville, Tennessee, United States

Site Status

Forest Investigative Site 1440

Arlington, Texas, United States

Site Status

Forest Investigative Site 1879

Boerne, Texas, United States

Site Status

Forest Investigative Site 1861

Carrollton, Texas, United States

Site Status

Forest Investigative Site 1816

Corsicana, Texas, United States

Site Status

Forest Investigative Site 1890

Dallas, Texas, United States

Site Status

Forest Investigative Site 1332

El Paso, Texas, United States

Site Status

Forest Investigative Site 2012

Fort Worth, Texas, United States

Site Status

Forest Investigative Site 1951

Houston, Texas, United States

Site Status

Forest Investigative Site 1091

McKinney, Texas, United States

Site Status

Forest Investigative Site 1826

Plano, Texas, United States

Site Status

Forest Investigative Site 1895

San Antonio, Texas, United States

Site Status

Forest Investigative Site 1936

Salt Lake City, Utah, United States

Site Status

Forest Investigative Site 1330

South Burlington, Vermont, United States

Site Status

Forest Investigative Site 1945

Newport News, Virginia, United States

Site Status

Forest Investigative Site 1404

Norfolk, Virginia, United States

Site Status

Forest Investigative Site 1120

Bellingham, Washington, United States

Site Status

Forest Investigative Site 1977

Spokane, Washington, United States

Site Status

Forest Investigative Site 1878

Spokane, Washington, United States

Site Status

Forest Investigative Site 1573

Spokane, Washington, United States

Site Status

Forest Investigative Site 0988

Tacoma, Washington, United States

Site Status

Forest Investigative Site 1870

Tacoma, Washington, United States

Site Status

Forest Investigative Site 1555

Morgantown, West Virginia, United States

Site Status

Forest Investigative Site 1991

New Lambton, New South Wales, Australia

Site Status

Forest Investigative Site 1987

Redcliffe, Queensland, Australia

Site Status

Forest Investigative Site 1973

Woolloongabba, Queensland, Australia

Site Status

Forest Investigative Site 2253

Adelaide, South Australia, Australia

Site Status

Forest Investigative Site 1981

Bedford Park, South Australia, Australia

Site Status

Forest Investigative Site 1990

Daw Park, South Australia, Australia

Site Status

Forest Investigative Site 2251

Toorak Gardens, South Australia, Australia

Site Status

Forest Investigative Site 2250

Clayton, Victoria, Australia

Site Status

Forest Investigative Site 1972

Fitzroy, Victoria, Australia

Site Status

Forest Investigative Site 1986

Geelong, Victoria, Australia

Site Status

Forest Investigative Site 1985

Parkville, Victoria, Australia

Site Status

Forest Investigative Site 1904

Langley, British Columbia, Canada

Site Status

Forest Investigative Site 905

Vancouver, British Columbia, Canada

Site Status

Forest Investigative Site 0976

Winnipeg, Manitoba, Canada

Site Status

Forest Investigative Site 1877

Sarina, Ontario, Canada

Site Status

Forest Investigative Site 1896

Sarnia, Ontario, Canada

Site Status

Forest Investigative Site 1171

Toronto, Ontario, Canada

Site Status

Forest Investigative Site 2203

Toronto, Ontario, Canada

Site Status

Forest Investigative Site 1952

Montreal, Quebec, Canada

Site Status

Forest Investigative Site 1859

Québec, Quebec, Canada

Site Status

Forest Investigative Site 0943

Saskatoon, Saskatchewan, Canada

Site Status

Forest Investigative Site 1027

Auckland, , New Zealand

Site Status

Forest Investigative Site 1970

Christchurch, , New Zealand

Site Status

Forest Investigative Site 1967

Dunedin, , New Zealand

Site Status

Forest Investigative Site 1964

Dunedin, , New Zealand

Site Status

Forest Investigative Site 1968

Hamilton, , New Zealand

Site Status

Forest Investigative Site 1965

Tauranga, , New Zealand

Site Status

Forest Investigative Site 1980

Tauranga, , New Zealand

Site Status

Forest Investigative Site 1025

Wellington, , New Zealand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Canada New Zealand

References

Explore related publications, articles, or registry entries linked to this study.

D'Urzo A, Rennard S, Kerwin E, Donohue JF, Lei A, Molins E, Leselbaum A. A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease. Respir Med. 2017 Apr;125:39-48. doi: 10.1016/j.rmed.2017.02.008. Epub 2017 Feb 16.

Reference Type DERIVED
PMID: 28340861 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LAC-MD-36

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.